Health Condition 1: C73- Malignant neoplasm of thyroid gland
Conditions
Interventions
Intervention1: LIGNOCAINE: INTRAVENOUS ROUTE
DOSE- IV BOLUS LIGNOCAINE 2% 0.5 MG/KG OVER 10 MINS FOLLOWED BY CONTINOUS INFUSION OF 0.5MG/KG/HR TILL 30 MINS BEFORE END OF SURGERY
Control Intervention1:
Sponsors
MGMCH
Eligibility
Inclusion criteria
Inclusion criteria: AGE- 18 TO 65 YEARS PATIENTS GIVING CONSENT PATIENTS UNDERGOING THYROIDECTOMY
Exclusion criteria
Exclusion criteria: PATIENTS ALLERGIC TO STUDY DRUGS PATIENTS ON BETA BLOCKER AND ANTI ARRTHYMIC DRUGS
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HEMODYNAMIC STATUS INTRAOPERATIVELYTimepoint: 6 HRS | — |
Secondary
| Measure | Time frame |
|---|---|
| COUGH GRADE AND EASE OF LARYNGOSCOPY TO CHECK MOBILITY OF VOCAL CORDS POST SURGERYTimepoint: 6 HRS | — |
Countries
India
Contacts
Public ContactVISHAKHA TANWAR
MAHATMA GANDHI MEDICAL COLLEGE AND HOSPITAL
Outcome results
None listed